MMCM
SBRA icon

Murphy & Mullick Capital Management’s Sabra Healthcare REIT SBRA Stock Holding History

Murphy & Mullick Capital Management’s Portfolio SBRA Stock Details SBRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$38.8K Buy
2,015
+7
+0.3% +$138 0.03% 315
2025
Q4 		$38K Buy
2,008
+1,008
+101% +$18.7K 0.03% 331
2025
Q3 		$17.5K Hold
1,000
– – 0.01% 407
2025
Q2 		$18.4K Hold
1,000
– – 0.02% 382
2025
Q1 		$17.5K Hold
1,000
– – 0.02% 379
2024
Q4 		$17.3K Buy
+1,000
New +$18.3K 0.02% 373

Other funds holding SBRA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Murphy & Mullick Capital Management's SBRA Position: Q1 2026 in Review

Murphy & Mullick Capital Management increased its Sabra Healthcare REIT (SBRA) stake by 0.35% in Q1 2026, buying an estimated $138 and bringing the position to 2,015 shares worth $38.8K. The position accounts for 0.03% of the portfolio, ranked #315.

Murphy & Mullick Capital Management first reported a position in SBRA in Q4 2024 and has held it in 6 quarters since. 459 funds tracked by Wall St. Rank hold SBRA as of Q1 2026.

  • Murphy & Mullick Capital Management held 2,015 shares of Sabra Healthcare REIT worth $38.8K as of Q1 2026.
  • Murphy & Mullick Capital Management bought 7 Sabra Healthcare REIT shares in Q1 2026, an estimated $138.
  • Sabra Healthcare REIT made up 0.03% of Murphy & Mullick Capital Management's portfolio in Q1 2026, its #315 holding.
  • Murphy & Mullick Capital Management first reported a position in Sabra Healthcare REIT in Q4 2024 and has held it in 6 quarters since.
  • 459 funds tracked by Wall St. Rank held Sabra Healthcare REIT as of Q1 2026.

Based on Murphy & Mullick Capital Management's 13F filing for Q1 2026, filed 17 Apr 2026.